drugset / Trial / NCT07448194
A Phase Ia Clinical Trial of HW241045
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase Ia, randomized, double-blind, placebo-controlled study to assess the safety, tolerability and pharmacokinetic (PK) of HW241045 in healthy subjects following a single ascending dose.
Timeline
- Start
- 2025-11-24
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HW241045 | Unknown | — | Oral |